Synthesis, Spectroscopic Analysis, Molecular Docking, Molecular Dynamics Simulation of 5-(Adamantan-1-yl)-4-(3-Chlorophenyl)-2,4-Dihydro-3H-1,2,4-Triazole-3-Thione, a Potential Anti-proliferative Agent

[1]  F. Sen,et al.  Quantum Computational Investigation of (E)-1-(4-methoxyphenyl)-5-methyl-N′-(3-phenoxybenzylidene)-1H-1,2,3-triazole-4-carbohydrazide , 2022, Molecules.

[2]  Y. Sert,et al.  New Heterocyclic Compound as Carbon Steel Corrosion Inhibitor in 1 M H2SO4, High Efficiency at Low Concentration: Experimental and Theoretical Studies , 2022, Journal of Adhesion Science and Technology.

[3]  N. Dege,et al.  Quantum computational, Spectroscopic Investigations on N-(2-((2-chloro-4,5-dicyanophenyl)amino)ethyl)-4-methylbenzenesulfonamide by DFT/TD-DFT with Different Solvents, Molecular Docking and Drug-Likeness Researches , 2022, Colloids and Surfaces A: Physicochemical and Engineering Aspects.

[4]  I. Gülçin,et al.  Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors , 2021, Archiv der Pharmazie.

[5]  H. Salman,et al.  Corrosion inhibition of carbon steel in 1 M H2SO4 using new Azo Schiff compound: Electrochemical, gravimetric, adsorption, surface and DFT studies , 2020 .

[6]  Zhiyuan Zhang,et al.  The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma , 2020, Cancer science.

[7]  G. Mills,et al.  p85β regulates autophagic degradation of AXL to activate oncogenic signaling , 2020, Nature Communications.

[8]  N. Issaeva,et al.  EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations , 2020, Annals of translational medicine.

[9]  Itraconazole , 2020, Reactions Weekly.

[10]  Holger Kruse,et al.  Exploring Nature and Predicting Strength of Hydrogen Bonds: A Correlation Analysis Between Atoms‐in‐Molecules Descriptors, Binding Energies, and Energy Components of Symmetry‐Adapted Perturbation Theory , 2019, J. Comput. Chem..

[11]  H. M. Hassan,et al.  Molecular docking, Hirshfeld surface analysis and spectroscopic investigations of 1-(adamantan-1-yl)-3-(4-fluorophenyl)thiourea: A potential bioactive agent , 2019, Chemical Physics Letters.

[12]  M. Walters,et al.  Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system , 2019, Scientific Reports.

[13]  K. Gelmon,et al.  Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up , 2019, Breast Cancer Research and Treatment.

[14]  M. Ohba,et al.  Receptor Tyrosine Kinase-Targeted Cancer Therapy , 2018, International journal of molecular sciences.

[15]  M. Foroozesh,et al.  The sphingosine kinase 2 inhibitor ABC294640 displays anti‐non‐small cell lung cancer activities in vitro and in vivo , 2018, International journal of cancer.

[16]  Andreas Eckert,et al.  ProTox-II: a webserver for the prediction of toxicity of chemicals , 2018, Nucleic Acids Res..

[17]  A. Al-majed,et al.  First principle study of a potential bioactive molecule with tetrahydroisoquinoline, carbothiomide and adamantane scaffolds , 2017 .

[18]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[19]  K. Kuča,et al.  Adamantane - A Lead Structure for Drugs in Clinical Practice. , 2016, Current medicinal chemistry.

[20]  Margaret A. Goralski,et al.  The Anti-tumor Toxin CD437 is a Direct Inhibitor of DNA Polymerase α , 2016, Nature chemical biology.

[21]  Berk Hess,et al.  GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .

[22]  E. Chowdhury,et al.  Growth factor receptors: promising drug targets in cancer , 2015 .

[23]  A. Asiri,et al.  Experimental (FT-IR, FT-Raman, UV and NMR) and quantum chemical studies on molecular structure, spectroscopic analysis, NLO, NBO and reactivity descriptors of 3,5-Difluoroaniline. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[24]  Abdul-Malek S. Al-Tamimi,et al.  Structural and spectroscopic characterization of a novel potential anti-inflammatory agent 3-(adamantan-1-yl)-4-ethyl-1H-1,2,4-triazole-5(4H)thione by first principle calculations. , 2014, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[25]  Y. Yamashita,et al.  The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment , 2013, BioMed research international.

[26]  P. Schreiner,et al.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives. , 2013, Chemical reviews.

[27]  Peter M. Kasson,et al.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..

[28]  G. Drewes,et al.  Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor. , 2013, Journal of medicinal chemistry.

[29]  Crispin R Dass,et al.  Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems , 2013, The Journal of pharmacy and pharmacology.

[30]  Hiroko Masuda,et al.  Role of epidermal growth factor receptor in breast cancer , 2012, Breast Cancer Research and Treatment.

[31]  Abdul-Malek S. Al-Tamimi,et al.  Structural and spectroscopic characterization of a novel potential chemotherapeutic agent 3-(1-adamantyl)-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-4-methyl-1H-1,2,4-triazole-5(4H)-thione by first principle calculations , 2012 .

[32]  M. Karabacak,et al.  The spectroscopic (FT-Raman, FT-IR, UV and NMR), molecular electrostatic potential, polarizability and hyperpolarizability, NBO and HOMO-LUMO analysis of monomeric and dimeric structures of 4-chloro-3,5-dinitrobenzoic acid. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[33]  M. Karabacak,et al.  FT-IR, FT-Raman and UV spectral investigation: computed frequency estimation analysis and electronic structure calculations on chlorobenzene using HF and DFT. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[34]  D. Obando,et al.  The many faces of the adamantyl group in drug design. , 2011, European journal of medicinal chemistry.

[35]  Yosef Yarden,et al.  Roles for growth factors in cancer progression. , 2010, Physiology.

[36]  Alexander D. MacKerell,et al.  CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..

[37]  A. D. de Lera,et al.  Inhibition of IkappaB kinase-beta and anticancer activities of novel chalcone adamantyl arotinoids. , 2008, Journal of medicinal chemistry.

[38]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[39]  Daryl S Schiller,et al.  Posaconazole: an extended-spectrum triazole antifungal agent. , 2007, Clinical therapeutics.

[40]  Matthew Meyerson,et al.  Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. , 2007, Cancer cell.

[41]  Kechen Ban,et al.  Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1 , 2007, Cancer Chemotherapy and Pharmacology.

[42]  M. Parrinello,et al.  Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.

[43]  R. Parthasarathi,et al.  Analyzing Toxicity Through Electrophilicity , 2006, Molecular Diversity.

[44]  J. Dobrowolski,et al.  Vibrational modes of 2,6-, 2,7-, and 2,3-diisopropylnaphthalene. A DFT study , 2006 .

[45]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[46]  Ping Chen,et al.  Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. , 2005, The Journal of antimicrobial chemotherapy.

[47]  R. Parthasarathi,et al.  Electrophilicity index as a possible descriptor of biological activity. , 2004, Bioorganic & medicinal chemistry.

[48]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[49]  András Fiser,et al.  ModLoop: automated modeling of loops in protein structures , 2003, Bioinform..

[50]  Robin Taylor,et al.  New software for searching the Cambridge Structural Database and visualizing crystal structures. , 2002, Acta crystallographica. Section B, Structural science.

[51]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[52]  V. Steele,et al.  Effect of the aromatase inhibitor vorozole on estrogen and progesterone receptor content of rat mammary carcinomas induced by 1-methyl-1-nitrosourea , 2001, Breast Cancer Research and Treatment.

[53]  I. Muegge,et al.  Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.

[54]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[55]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[56]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[57]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[58]  A. Becke.  Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[59]  R. Bader,et al.  A quantum theory of molecular structure and its applications , 1991 .

[60]  R. Parr,et al.  Principle of maximum hardness , 1991 .

[61]  Hermann Stoll,et al.  Results obtained with the correlation energy density functionals of becke and Lee, Yang and Parr , 1989 .

[62]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[63]  Hoover,et al.  Canonical dynamics: Equilibrium phase-space distributions. , 1985, Physical review. A, General physics.

[64]  S. Nosé.  A molecular dynamics method for simulations in the canonical ensemble , 1984 .

[65]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[66]  M. Parrinello,et al.  Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .

[67]  T. Sundius.  A new damped least-squares method for the calculation of molecular force fields , 1980 .

[68]  S. Pell,et al.  Trial of amantadine in epidemic influenza , 1966, Clinical pharmacology and therapeutics.

[69]  M. Paulshock,et al.  Antiviral Activity of 1-Adamantanamine (Amantadine) , 1964, Science.

[70]  L. Sheng,et al.  Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action. , 2013, Oncology letters.

[71]  Ping Chen,et al.  Discovery of dipiperidines as new antitubercular agents. , 2010, Bioorganic & medicinal chemistry letters.

[72]  U. Sarkar,et al.  Electrophilicity index. , 2006, Chemical reviews.

[73]  V. Krishnakumar,et al.  Density functional theory calculations and vibrational spectra of 3,5-dibromopyridine and 3,5-dichloro-2,4,6-trifluoropyridine. , 2005, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[74]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.